Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.

Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Abstract Text:

    lisa g horvathLisa G Horvath,susan m henshallSusan M Henshall,james g kenchJames G Kench,jennifer j turnerJennifer J Turner,david golovskyDavid Golovsky,phillip c brennerPhillip C Brenner,gordon f o'neillGordon F O'Neill,raji koonerRaji Kooner,phillip d strickerPhillip D Stricker,john j grygielJohn J Grygiel,robert l sutherlandRobert L Sutherland,

    BACKGROUND: The role of the bone morphogenetic protein (BMP) pathway in prostate cancer (PC) is unclear. This study aimed to characterize aspects of the BMP pathway in PC by assessing BMP2, Smad8, and Smad4 expression in normal, hyperplastic, and malignant prostate tissue, and to correlate findings with progression to PC. METHODS: Radical prostatectomy (RP) specimens from 74 patients with clinically localized PC (median follow-up 51 months, range 15-152), 44 benign prostatic hypertrophy (BPH) lesions, and 4 normal prostates (NPs) were assessed for BMP2, Smad8, and Smad4 expression using immunohistochemistry. RESULTS: Both BMP2 (P < 0.001) and nuclear Smad4 (P < 0.0001) expression were significantly decreased in PC compared to benign prostate tissue. Nuclear Smad8 was present in normal/benign prostate tissue but absent in PC and adjacent hyperplasia. Furthermore, loss of BMP2 (P < 0.001) and decreased nuclear Smad4 (P = 0.05) expression correlated with increasing Gleason score. CONCLUSIONS: These data suggest that decreased BMP2, nuclear smad8 and nuclear Smad4 expression are associated with the progression to PC, and in particular loss of BMP2 and Smad4 are related to progression to a more aggressive phenotype.

    Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Publishing Authors By Initials

    lg horvathLG Horvath,sm henshallSM Henshall,jg kenchJG Kench,jj turnerJJ Turner,d golovskyD Golovsky,pc brennerPC Brenner,gf o'neillGF O'Neill,r koonerR Kooner,pd strickerPD Stricker,jj grygielJJ Grygiel,rl sutherlandRL Sutherland,

    For similar peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research

    PUBMED ID PMID:

    MEDLINE DATE:

    Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Prostate

    VOLUME: 59

    Page Numbers: 234-42

    Journal Abbreviation: Prostate

    ISSN: 0270-4137

    DAY: 15

    MONTH: May

    YEAR: 2004

    Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8101368

    Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Keywords Mesh Terms:

    KEYWORDS: Transforming Growth Factor beta

    MESH TERMS: biosynthesis

    Chemical & Substance for Abstract: Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Information

    Substance Name: bone morphogenetic protein 2

    Registry Number: 0

    Grant and Affiliation Information for Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.

    AFFILIATION: Cancer Research Program, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, Sydney, NSW, Australia.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Prostate

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News